The medications are expensive, though some insurance does cover them for appropriate indications
Change rarely follows a single step
3094, issuing a Transfer Order to centralize lawsuits claiming that the manufacturers of GLP-1 RA weight-loss drugs, such as Ozempic, Wegovy, and Rybelsus, did not adequately warn patients and doctors about the risk of severe gastrointestinal side effects
Many patients were not informed by Novo Nordisk or their doctors that blindness caused by NAION was a potential complication
The $50 copay is only for weight loss If you're already taking one of these medications for a qualifying condition such as Type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea, you'll continue to get it through your regular Part D plan